Министерство здравоохранения и социального развития РФ ФГУ Эндокринологический научный центр. Объемные образования надпочечников (диагностика и дифференциальная диагностика). Методические рекомендации для врачей, оказывающих специализированную медицинскую

Дедов И.И., Мельниченко Г.А., Трошина Е.А., Молашенко Н.В., Юкина М.Ю., Бельцевич Д.Г., Ремизов О.В. Министерство здравоохранения и социального развития РФ ФГУ Эндокринологический научный центр. Объемные образования надпочечников (диагностика и дифференциальная диагностика). Методические рекомендации для врачей, оказывающих специализированную медицинскую помощь (сокращенный вариант). Consilium Medicum. 2009; 11 (12): 76–94.

Читать PDF

Список литературы
Авторы

Список литературы

Arnaldi G et al. Adrenal incidentaloma. Braz J Med Biol Res 2000; 33 (10): 1177–89.
Allolio B, Fassnacht M. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006; 91: 2027–37.
Terzolo M et al. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997; 132 (8): 914–9.
Allolio B. Adrenal Incidentalomas. Adrenal Disorders, ed. C.G.Margioris AN. Totowa: Humana Press Inc. New Jersey 2001; p. 249–61.
Mantero F et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85 (2): 637–44.
Russi S et al. Small adenomas of the adrenal cortex in hypertension and diabetes. Arch Intern Med 1945; 76: 284–91.
Commons R.R. et al. Adenomas of the adrenal cortex. Arch Intern Med 1948; 81: 37–41.
Shamma A.H., Sommers S.C. et al. A study of the adrenal status in hypertension. J Chron Dis 1958; 8: 587–95.
Kokko J.P., Bermann M.M. et al. Adrenal adenoma and hypertension. Lancet 1967; 1: 468–70.
Hedeland H, HniЅkfelt B et al. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 1968; 184: 211–4.
Reinhard C, Schubert B et al. Nodules and adenomas in the adrenal cortex: Incidence in post - mortem series and correlation with clinical data. Exp Clin Endocrinol 1994; 102 (Suppl. 1): 192.
Glazer H.S. et al. Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol 1982; 139 (1): 81–5.
Garz G, Luning M, Melzer B. Computed tomographic incidental finding of a hormone - inactive adrenal cortex adenoma. Radiol Diagn 1985; 26 (6): 761–6.
Kley H.K., Jaresch S, Jungblut R, Schlaghecke R. Endokrin inaktive Nebennierentumoren., in Moderne Diagnostik und therapeutische Strategien bei Nebennierenerkrankungen. Allolio B, editor. 1990. Schattauer: New York. p. 189–97.
Stark S, Sachse R, Cidlinski K et al. Endocrine inactive adrenocortical adenomas (ACA) are a condition of the eldery. Exp Clin Endocrinol 1994; 102 (Suppl. 1): 193.
Herrera M.F. et al. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991; 110 (6): 1014–21.
Kasperlik-Zeluska A.A. et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997; 46 (1): 29–37.
Linos D, van Herden J.A. Adrenal glands. Diagnostic aspects and surgical therapy. Springer. Berlin 2005; P. 41–251.
Kloos R.T., Gross M.D., Francis I.R. et al. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460–84.
Latronico A.C., Chrousos G.P. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 1997; 82 (5): 1317–24.
NIH, Management of the Clinically Inapparent Adrenal Mass ("Incidentaloma"), in State - of -the - science Conference Statement. 2002, National Institute of Health. Hormones 2003; 2 (1): 9–11.
Reincke M et al. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 1996; 22 (4): 757–61.
Barzon L et al. Risk factors and long - term follow - up of adrenal incidentalomas. J Clin Endocrinol Metab 1999; 84 (2): 520–6.
Libe R et al. Long - term follow - up study of patients with adrenal incidentalomas. Eur J Endocrinol 2002; 147 (4): 489–94.
Funder J.W. et al. Guidelines for Management of Patients with Primary Aldosteronism. J Clin Endocrin Metab 2008; 93 (9): 3266–81.
Бельцевич Д.Г. (перевод) Первичный гиперальдостеронизм. Клинические рекомендации. Эндокрин. хир. 2008; 2 (3): 6–20.
Mattsson C, Young Jr.W.F. Primary aldosteronism: diagnostic and treatment strategies. Nature Clin Pract Nephrol 2006; 2 (4): 198–208.
Павленко А.К., Фадеев В.В., Мельниченко Г.А. Диагностика первичного гиперальдостеронизма. Пробл. эндокринол. 2001; 2: 15–25.
Трошина Е.А., Бельцевич Д.Г., Молашенко Н.В. Первичный гиперальдостеронизм. Пробл. эндокринол. 2008; 6: 43–9.
Young W.F.Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 2208–13.
Montori V.M., Young W.F.Jr. Use of plasma aldosterone concentration - to - plasma renin activity ratio as a screening test for primary aldosteronism: a systematic review of the literature. Endocrinol Metab Clin North Am 2002; 31: 619–32.
Tiu S.C., Choi C.H., Shek C.C. et al. The use of aldosterone - renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90: 72–8.
Schwartz G.L., Turner S.T. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005; 51: 386–94.
Seiler L, Rump L.C., Schulte-Monting J et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol 2004; 150: 329–37.
Mulatero P, Rabbia F, Milan A et al. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002; 40: 897–902.
Young Jr.W.F., Stanson A.W., Thompson G.B. et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227–35.
Дедов И.И., Мельниченко Г.А. Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ. М.: Литтерра, 2006; с. 488–510.
Марова Е.И., Арапова С.Д., Бельченко Л.В. Болезнь Иценко – Кушинга, методическое пособие для врачей. М., 2000.
Мельниченко Г.А., Марова Е.И., Дзеранова Л.К и др. Диагностика и лечение нейроэндокринных заболеваний, методическое пособие для врачей. М., 2003; с. 3–16.
Raff H, Findling J.W. A Physiologic Approach to Diagnosis of the Cushing Syndrome. Ann Intern Med 2003; 138 (12): 980–91.
Nieman L.K., Biller B.M.K., Findling J.W. et al. The Diagnosis of Cushing\'s Syndrome: An Endocrine Society Clinical Practice Guideline Journal of Clinical Endocrinology & Metabolism. 2008; 93 (5): 1526–40.
Reincke M et al. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 1996; 22 (4): 757–61.
Rossi R, Tauchmanova L, Luciano A et al. Subclinical Cushing\'s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000; 85: 1440–8.
Terzolo M et al. Subclinical Cushing\'s Syndrome. Pituitary 2004; 7 (4): 217–23.
Reincke M et al. Preclinical Cushing\'s syndrome in adrenal «incidentalomas»: comparison with adrenal Cushing\'s syndrome. J Clin Endocrinol Metab 1992; 75 (3): 826–32.
Reincke M et al. Subclinical Cushing\'s syndrome. Endocrinol Metab Clin North Am 2000; 29 (1): 43–56.
Torlontano M et al. Pre-Cushing\'s syndrome not recognized by conventional dexamethasone suppression - tests in an adrenal «incidentaloma» patient. J Endocrinol Invest 1997; 20 (8): 501–4.
Valli N et al. Biochemical screening for subclinical cortisol - secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 2001; 144: 401–8.
Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. Jama 1989; 261 (6): 894–8.
Дедов И.И., Бельцевич Д.Г., Кузнецов Н.С., Мельниченко Г.А. Феохромоцитома. Практическая медицина. М., 2005; с. 11–191.
Кузнецов Н.С., Бельцевич Д.Г., Лысенко М.А. Феохромоцитома. Врач. М., 2002; 7: 23–7.
McNeil AR, Blok BH, Koelmeyer TD et al. Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N J Med 2000; 30 (6): 648–52.
Pacak K et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 2007; 3: 92–102.
Бельцевич Д.Г. (перевод) Феохромоцитома: клинические рекомендации 1 международного симпозиума (ISP). Эндокрин. хирур. 2007; 1 (1): 3–12.
Lack E.E. et al. Recommendations for the reporting of extra - adrenal paragangliomas. The Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 2003; 34: 112–3.
Lenders J.W. et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427–34.
Guller U et al. Detecting pheochromocytoma: defining the most sensitive test. Ann Surg 2006; 243: 102–7.
Ilias I et al. 6-[18F]-fluorodopamine positron emission tomography versus [131I]metaiodobenzylguanidine scintigraphy in the evaluation of patients with pheochromocytoma. Abstract P3-511. Presented at the 84th Annual Meeting of the Endocrine Society: 2002 June 19–22; San Fransisco, CA.
Furuta N et al. Diagnosis of pheochromocytoma using [123I]compared with [131I]-metaiodobenzylguanidine scintigraphy. Int J Urol 1999; 6: 119–24.
Eisenhofer G et al. Pheochromocytoma: rediscovery as a catecholamine - metabolizing tumor. Endocr Pathol 2003; 14: 193–212.
Terzolo M et al. Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab 1996; 81 (2): 740–4.
Flecchia D et al. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour. Clin Endocrinol (Oxf) 1995; 42 (2): 129–34.
Orentreich N et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59 (3): 551–5.
Петеркова В.А., Семичева Т.В., Кузнецова Э.С. и др. Врожденная дисфункция коры надпочечников у детей. Пособие для врачей. М., 2003.
Young W.F.Jr. The Incidentally Discovered Adrenal Mass. N Engl J Med 2007; 356: 601–10.
Lee J.E., Evans D.B., Hickey R.C. et al. Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 1998; 124: 1115–22.
Кузнецов Н.С., Dанушко В.Э., Ким И.В. Современные диагностические методы в эндокринологии. Эндокрин. хирур. 2007; 1 (1): 13–9.
Rezneck R.H., A.P. Imaging in endocrinology. The adrenal gland. Clin Endocrinol 1994; 40: 561–76.
Korobkin M, Brodeur F.J., Francis I.R. et al. CT time attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170: 747–52.
Pena C.S., Boland G.W., Hahn P.F. et al. Characterization of indeterminate (lipid - poor) adrenal masses: use of washout characteristics at contrast - enhanced CT. Radiology 2000; 217: 798–802.
Hussain H.K., Korobkin M. MR imaging of the adrenal glands. Magn Reson Imaging Clin N Am 2004; 12: 515–44.
Korobkin M et al. Characterization of adrenal masses with chemical shift and gadolinium - enhanced MR imaging. Radiology 1995; 197 (2): 411–8.
Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: differentiation with chemical shift, fast low - angle shot MR imaging. Radiology 1993; 186 (3): 705–9.
Saeger W, Beuschlein F, Prager G et al. Ex - vivo biopsies of adrenal lesiona: Morphology of 231 cases. Exp Clin Endocrinol Diabet 2001; 109 (Suppl. 1): S19, v76.
Yankaskas B.C. et al. Delayed complications from fine - needle biopsies of solid masses of the abdomen. Invest Radiol 1986; 21 (4): 325–8.
Silverman S.G. et al. Predictive value of image - guided adrenal biopsy: analysis of results of 101 biopsies. Radiology 1993; 187 (3): 715–8.
Mc Corkell S.J., Niles N.L. Fine - needle aspiration of catecholamine - producing adrenal masses: a possibly fatal mistake. AJR Am J Roentgenol 1985; 145 (1): 113–4.

Авторы

Дедов И.И., Мельниченко Г.А., Трошина Е.А., Молашенко Н.В., Юкина М.Ю., Бельцевич Д.Г., Ремизов О.В.

Назад к списку

Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.

Ключевые слова